Welcome to New Pathways Ketamine clinics, offering ketamine infusions and ketamine-assisted psychotherapy to clients with treatment-resistant mood and anxiety conditions in the San Francisco Bay Area.
As a young neuroscience researcher, I observed the symptoms of those with longstanding mood conditions diminish or disappear with the help of the novel medicines or treatments. It was incredibly rewarding to see the relief on patients’ faces and watch regain their sense of self. I have continually incorporated leading-edge, evidence-based treatments into my practice, to give patients the best therapy options possible.
We are living in an exciting age, where psychiatry is making inroads into alleviating persistent mood and anxiety conditions. Ketamine creates a more open state of mind and stimulates the formation of new synapses, decreasing symptoms in as quickly as a few days or even hours. It is proving to be a remarkably safe and effective tool in relieving those who have suffered for many years with depression, anxiety, OCD, PTSD, and suicidal drive.
Our clinic’s budding tree logo represents the growth of new synapses that ketamine therapy encourages; with this new growth comes relief from the painful symptoms of treatment-resistant mood and anxiety conditions. It also represents our sincere wish that ketamine treatments will provide hope, fresh outlooks, and new life paths for our patients.
To best serve our patients, we have created two ketamine program options. We offer a standalone ketamine-infusion therapy, as well as a unique ketamine-assisted psychotherapy program. By actively engaging patients in recovery, processing their experiences, and reinforcing new thought and behavior patterns, therapy sessions may help encourage synaptic growth and a sustained sense of well-being. In addition, we continue to explore ketamine’s incredible potential to heal through non-ordinary states of consciousness.
If you’re considering ketamine therapy, chances are you’ve already tried multiple lines of treatment. We understand that searching for the right therapy can be a difficult process, especially while experiencing symptoms.
Whatever treatment or clinic you chose, we wish you the very best of health.
— Roberto Estrada, MD
Medical Director, New Pathways Ketamine Center
Roberto Estrada, MD – Medical Director
As a nationally-recognized clinical expert in the field of Interventional Psychiatry and Neuromodulation, Dr. Estrada has over 15 years of experience with the latest in cutting-edge technology to treat patients with mood and anxiety disorders. He has been using Transcranial Magnetic Stimulation (TMS), Electroconvulsive Therapy (ECT) Vagus Nerve Stimulation (VNS) and now Ketamine Infusion Therapy (KIT) safely and effectively to help thousands of patients suffering with severe and debilitating depression.
Dr. Estrada formed Lenox Hill TMS Psychiatric Associates in 2009, and has served as Medical Director for the San Francisco office. He has now formed Ketamine Center of San Francisco, a specialty clinic designed to provide the various forms of Ketamine therapy to treat Mood Disorders.
Dr. Estrada completed his Residency training in Adult Psychiatry, where he served as Chief Resident, and Fellowship training in Geriatric Psychiatry at New York University (NYU) School of Medicine. He completed Visiting Fellowships in ECT and TMS at Columbia University Medical Center and has also received formal clinical training in VNS. He recently completed training in Ketamine Therapy at the Psychedelic Sciences Conference and Kaiser Permanente Ketamine Conference.
After completing his training, he joined the Attending Staff at Lenox Hill Hospital where he served as the Assistant Director of Inpatient and Emergency Psychiatry (2006) and Chief of ECT Services (2004-2015). He remains on the Voluntary staff at Lenox Hill Hospital and is an Assistant Clinical Professor of Psychiatry at the NYU School of Medicine.
Dr. Estrada is a Diplomate of the American Board of Psychiatry and Neurology and is a Fellow of the American Psychiatric Association. He is an active member of the International Society of ECT and Neurostimulation (ISEN) and the Clinical TMS Society, where he has worked diligently to advocate for mental health parity and increase awareness of novel psychiatric treatments.